- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 3rd, 2008
It takes 20 years, give or take, for a new technology to move through multiple cycles of development, commercialization, and competition necessary to evolve from experimental prototype to widespread maturity. A look back at the past few decades of medical progress suggests that 30 years is more likely in that field - there's one effect of regulation for you, a slowing of the technologies that manage to make it over the regulatory hurdle in the first place.
What does this pace of progress in medicine mean for middle-aged and younger people today? It means that the 2030s will see widespread, cost-effective use of the medical technologies you presently read about in the science press. A small selection:
* Replacement organs will be grown to order from your own cells.
* Stem cells will be created, manipulated, and transplanted to direct extraordinary regeneration
* Age-damaged immune systems will be wiped clean and replaced afresh.
* Gene therapy will be a mature technology, and genetic disorders curable.
* Everyone will know their DNA sequence, and have access to a vast database of knowledge that describes risks, therapies, and best practices.
* Cancer will be detected early, and even late-stage metastasis cured with few side-effects by nanoparticle-based, viral, or other therapies.
* The important mitochondrial DNA will be replaced when damaged by disease or age.
* Many of the biochemical processes underlying the benefits of exercise, calorie restriction, and known human longevity-associated genes will be reproduced by cheap drugs.
|Related News Press|
News and information
Graphenea celebrates fifth anniversary April 27th, 2015
Graphene chips are close to significant commercialization October 1st, 2014
Indefinite Life Extension Activists Organize Online Demonstration February 26th, 2015
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012